Asia-Pacific Healthcare 3D Printing Market to surpass USD 340 million by 2024

March 05, 2020


According to the research report titled ‘Asia Pacific Healthcare 3D Printing Market Size by Product, Application, Technology, Industry Analysis Report, Country Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024’, available with Market Study Report LLC, Asia-Pacific healthcare 3D printing market is expected to cross USD 340 million by the year 2024.
 

As per the report, growing demand for personalized implants is a major factor driving the growth of Asia-Pacific healthcare 3D printing industry. There has been an upsurge in number of cases related to trauma and accidents, which has fostered the demand for personalized medical implants and prosthetic limbs. This factor along with increasing utilization of 3D printing technology across numerous healthcare applications is further aiding the market expansion. Also, shifting focus of manufacturers towards developing innovative 3D printing technologies and availability of technologically advanced 3D printing solutions are stimulating the industry outlook. However, high cost associated with 3D printing software and dearth of skilled professional may hinder the overall market growth.
 

Based on product landscape, the report states that laser based 3D printing market segment held 18% revenue share in the year 2017 and is expected to grow continuously during the forecast period. Laser printers quicken DNA printing processes, hence helps in effective and affordable development of medicines. Rising adoption of laser based printers for DNA synthesis is fueling the segmental growth.
 

In terms of technology, selective laser sintering segment is presumed to expand with a CAGR of 21% during the period of 2018-2024. This type of technology can word with plastic, glass, metal, and ceramic materials to develop 3D objects without the need of support structures.
 

The report claims that dental application of healthcare 3D printing in Asia-Pacific was valued at USD 25 million in the year 2017 and will witness consistent growth throughout the analysis timeframe. Increasing application of 3D printing for prosthodontics models, orthopedic implants, fabrication of copings, and craniomaxillofacial in dentistry are favoring the market outlook.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2506064/
 

Considering the geographical landscape, the report cites that China healthcare 3D printing industry was worth USD 15 million in the year 2017 and is poised to acquire notable gains in the forthcoming years. Advancements in 3D printing technology, improvement in healthcare infrastructure, and large patient population are augmenting the healthcare 3D printing industry landscape in China.
 

The prominent companies operating in Asia-Pacific healthcare 3D printing industry are Zortrax, Zenith Tecnica, Stratasys, Renishaw, Materialise, Envision TEC, BioBots, Bio 3D Technologies, Aspect Biosystems, Altem Technologies, and 3D Bioprinting Solutions.


Frequently Asked Questions (FAQ) :

According to the report, growing demand for personalized implants is a major factor driving the growth of Asia-Pacific healthcare 3D printing industry. There has been an upsurge in number of cases related to trauma and accidents, which has fostered the demand for personalized medical implants and prosthetic limbs. This factor along with increasing utilization of 3D printing technology across numerous healthcare applications is further aiding the market expansion. Also, shifting focus of manufacturers towards developing innovative 3D printing technologies and availability of technologically advanced 3D printing solutions are stimulating the industry outlook.
The report states that laser based3D printing market segment held 18% revenue share in the year 2017 and is expected to grow continuously during the forecast period. Laser printers quicken DNA printing processes, hence helps in effective and affordable development of medicines. Rising adoption of laser based printers for DNA synthesis is fueling the segmental growth.
The report cites that China healthcare 3D printing industry was worth USD 15 million in the year 2017 and is poised to acquire notable gains in the forthcoming years. Advancements in 3D printing technology, improvement in healthcare infrastructure, and large patient population are augmenting the healthcare 3D printing industry landscape in China.
The prominent companies operating in the Asia-Pacific healthcare 3D printing industry are Zortrax, Zenith Tecnica, Stratasys, Renishaw, Materialise, Envision TEC, BioBots, Bio 3D Technologies, Aspect Biosystems, Altem Technologies, and 3D Bioprinting Solutions.